Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer

被引:0
|
作者
Matsumoto, A. [1 ]
Jinno, H. [2 ]
Ando, T. [1 ]
Fujii, T. [1 ]
Nakamura, T. [1 ]
Saito, J. [1 ]
Takahashi, M. [2 ]
Hayashida, T. [2 ]
Kitagawa, Y. [2 ]
机构
[1] Inagi Municipal Hosp, Dept Surg, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan
来源
BREAST | 2015年 / 24卷
关键词
D O I
10.1016/S0960-9776(15)70241-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P207
引用
收藏
页码:S96 / S97
页数:2
相关论文
共 50 条
  • [1] Prognostic significance of biomarker discordance in breast cancer patients with neoadjuvant chemotherapy
    Matsumoto, A.
    Yoshikawa, M.
    Jinno, H.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 19 - 19
  • [2] Prognostic Significance of Biomarker Discordance in Breast Cancer Patients with Neoadjuvant Chemotherapy
    Matsumoto, Akiko
    Yoshikawa, Mio
    Takahashi, Yoko
    Jinno, Hiromitsu
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer
    Dawood, Shaheenah
    Gonzalez-Angulo, Ana M.
    [J]. CANCER BIOMARKERS, 2012, 12 (06) : 241 - 250
  • [4] Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer
    Kurihara, Toshiaki
    Ueno, Hanako
    Takemae, Masaru
    Nagayama, Aiko
    Takahashi, Maiko
    Hayashida, Tetsu
    Jinno, Hiromitsu
    Kitagawa, Yuko
    [J]. CANCER RESEARCH, 2015, 75
  • [5] Biomarker Changes After Neoadjuvant Chemotherapy for Breast Cancer
    Maguire, Aoife
    Hudson, Andrew
    Jagas, Jacob
    Quinn, Cecily
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S178 - S178
  • [6] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    [J]. Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [7] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
    Tanei, T.
    Shimomura, A.
    Shimazu, K.
    Nakayama, T.
    Kim, S. J.
    Iwamoto, T.
    Tamaki, Y.
    Noguchi, S.
    [J]. EJSO, 2011, 37 (02): : 155 - 161
  • [8] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [9] Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy
    Zarotti, Cristina
    Papassotiropoulos, Barbel
    Elfgen, Constanze
    Dedes, Konstantin
    Vorburger, Denise
    Pestalozzi, Bernhard
    Trojan, Andreas
    Varga, Zsuzsanna
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] CHANGES IN BIOMARKER STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Matsumoto, A.
    Takahashi, M.
    Hayashida, T.
    Hirose, S.
    Jinno, H.
    Kitagawa, Y.
    [J]. BREAST, 2013, 22 : S64 - S64